← Back to headlines
H.B. Fuller Projects FY2026 EBITDA Amidst Acquisition Progress
H.B. Fuller has provided an outlook for its fiscal year 2026 EBITDA, projecting a range of $650M-$675M, as it continues to advance its acquisition of Advanced Medical Solutions.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.


